Literature DB >> 26611558

Glucocorticoid-induced Osteoporosis.

Xena Whittier1, Kenneth G Saag2.   

Abstract

Glucocorticoid-induced osteoporosis (GIOP) is one of the most common and serious adverse effects associated with glucocorticoid use. This article highlights GIOP pathophysiology, epidemiologic associations, effective treatment, and lifestyle modifications that can reduce fracture risk for long-term glucocorticoid users and additionally emphasizes the importance of early intervention.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Fracture risk; Glucocorticoids; Osteoporosis; Prevention

Mesh：

Substances：

Year:  2015        PMID： 26611558     DOI： 10.1016/j.rdc.2015.08.005

Source DB:  PubMed          Journal:  Rheum Dis Clin North Am        ISSN： 0889-857X            Impact factor:   2.670


  31 in total

Review 1.  Adverse bone effects of medications used to treat non-skeletal disorders.

Authors:  N B Watts
Journal:  Osteoporos Int       Date:  2017-07-27       Impact factor: 4.507

2.  The effects of bone metabolism in different methylprednisolone pulse treatments for Graves' ophthalmopathy.

Authors:  Yong-Xin Hu; Ren-Dong Zheng; Yao-Fu Fan; Li Sun; Xin Hu; Chao Liu
Journal:  Exp Ther Med       Date:  2019-11-08       Impact factor: 2.447

Review 3.  Protecting Bone Health in Pediatric Rheumatic Diseases: Pharmacological Considerations.

Authors:  Yujuan Zhang; Diana Milojevic
Journal:  Paediatr Drugs       Date:  2017-06       Impact factor: 3.022

Review 4.  Molecular and cellular mechanisms linking air pollution and bone damage.

Authors:  Diddier Prada; Gerard López; Helena Solleiro-Villavicencio; Claudia Garcia-Cuellar; Andrea A Baccarelli
Journal:  Environ Res       Date:  2020-04-06       Impact factor: 6.498

5.  Clinical management of osteoporotic vertebral fracture treated with percutaneous vertebroplasty.

Authors:  Anna Capozzi; Giovanni Scambia; Alessandro Pedicelli; Maurizio Evangelista; Roberto Sorge; Stefano Lello
Journal:  Clin Cases Miner Bone Metab       Date:  2017-10-25

6.  Chronic Corticosterone Treatment During Adolescence Has Significant Effects on Metabolism and Skeletal Development in Male C57BL6/N Mice.

Authors:  Scott A Kinlein; Ziasmin Shahanoor; Russell D Romeo; Ilia N Karatsoreos
Journal:  Endocrinology       Date:  2017-07-01       Impact factor: 4.736

7.  A Novel Hybrid Compound LLP2A-Ale Both Prevented and Rescued the Osteoporotic Phenotype in a Mouse Model of Glucocorticoid-Induced Osteoporosis.

Authors:  Geetha Mohan; Evan Yu-An Lay; Haley Berka; Lorna Ringwood; Alexander Kot; Haiyan Chen; Wei Yao; Nancy E Lane
Journal:  Calcif Tissue Int       Date:  2016-09-27       Impact factor: 4.333

8.  International Union of Basic and Clinical Pharmacology. CIX. Differences and Similarities between Human and Rodent Prostaglandin E2 Receptors (EP1-4) and Prostacyclin Receptor (IP): Specific Roles in Pathophysiologic Conditions.

Authors:  Xavier Norel; Yukihiko Sugimoto; Gulsev Ozen; Heba Abdelazeem; Yasmine Amgoud; Amel Bouhadoun; Wesam Bassiouni; Marie Goepp; Salma Mani; Hasanga D Manikpurage; Amira Senbel; Dan Longrois; Akos Heinemann; Chengcan Yao; Lucie H Clapp
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

9.  Local Administration of Methylprednisolone Laden Hydrogel Enhances Functional Recovery of Transected Sciatic Nerve in Rat.

Authors:  Ali Mehrshad; Mohammad Shahraki; Shahin Ehteshamfar
Journal:  Bull Emerg Trauma       Date:  2017-10

Review 10.  Mind the (treatment) gap: a global perspective on current and future strategies for prevention of fragility fractures.

Authors:  N C W Harvey; E V McCloskey; P J Mitchell; B Dawson-Hughes; D D Pierroz; J-Y Reginster; R Rizzoli; C Cooper; J A Kanis
Journal:  Osteoporos Int       Date:  2017-02-07       Impact factor: 4.507
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.